For anyone interested in investing in the health-care space, JPMorgan's annual Health Care Conference has become one of the most important events of the year. We were not able to get to San Francisco this year, but one of our favorite Odd Lots guests, James van Geelen of CitriniResearch.com, was in attendance. He called into this week's episode of Lots More to tell us what the leading players in health care and medical technology are buzzing about right now — and he confirms that AI and GLP-1 weight loss drugs are at the top of everyone's mind."
See omnystudio.com/listener for privacy information.
The Economist Who Believes AI Will Be Great for the Middle Class
Lots More on the Big Can Kick in Commercial Real Estate
Why Home Insurance Markets in California and Florida Imploded
How the US Dollar Became an International Weapon of War
Why the UAE Is Pumping $35 Billion Into Egypt
Industrial Policy and the Forgotten Side of Alexander Hamilton
Why We're Now Living in The Golden Age of Snack Food
Moderna's CFO on How to Allocate Capital in Big Pharma
Lots More on Why Japanese Stocks Are Surging
Celsius CEO Explains How They Win in Energy Drinks
Introducing: The Deal with Alex Rodriguez and Jason Kelly
Anat Admati on How to Never Bail Out Banks Again
How to Put a Price on a Bird: the Forgotten Science of Economic Ornithology
What Really Goes Into the Fed's Favorite Measure of Inflation?
How the Rise of 'Pod Shops' Is Reshaping the Way Markets Trade
How Ukraine Delivers the Mail During Wartime
A Longtime Aerospace Analyst Questions Boeing's Future
This Is What's Hard About Building a US Domestic Battery Industry
Lots More on What Earnings Are Telling Us About Prices Now
The Quiet Revolution in How We Rescue Banks
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
The Daily
TED Radio Hour
FT Alphachat
Freakonomics Radio
Goldman Sachs Exchanges